This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A European perspective of the cost effectiveness of facial composite tissue allotransplantation
European Journal of Plastic Surgery Open Access 25 November 2019
-
Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival
Scientific Reports Open Access 25 June 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fryer, M. et al. Expert Rev. Clin. Immunol. 11, 1189–1204 (2015).
Plock, J.A. et al. Transplantation 99, 1765–73 (2015).
Dolgin, E. Nat. Med. 18, 12–16 (2012).
Leonard, D. A. et al. Am. J. Transplant. 14, 343–355 (2014).
Schneeberger, S. et al. Ann. Surg. 257, 345–351 (2013).
Hivelin, M. et al. Arch. Immunol. Ther. Exp. http://dx.doi.org/10.1007/s00005-015-0380-8 (2015).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keener, A. Saving face: The search for alternatives to life-long immunosuppression for face transplants. Nat Med 22, 448–449 (2016). https://doi.org/10.1038/nm0516-448
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0516-448
This article is cited by
-
Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival
Scientific Reports (2019)
-
A European perspective of the cost effectiveness of facial composite tissue allotransplantation
European Journal of Plastic Surgery (2019)